skip to content

Woolfrey, Michael Richard

CPSO#: 63967

MEMBER STATUS
Active Member as of 27 Jun 1992
CURRENT OR PAST CPSO REGISTRATION CLASS
Restricted as of 05 Jul 2017

Summary

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui. Vivamus suscipit tortor eget felis porttitor volutpat. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur aliquet quam id dui posuere blandit. Vivamus suscipit tortor eget felis porttitor volutpat. Curabitur arcu erat, accumsan id imperdiet et, porttitor at sem. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui. Donec sollicitudin molestie malesuada. Pellentesque in ipsum id orci porta dapibus.

Former Name: No Former Name

Gender: Male

Languages Spoken: English

Education: Memorial University of Newfoundland Facu, 1991

Practice Information

Primary Location of Practice
270 King George Road
Brantford ON  N3R 1G9
Phone: (519) 900-5575
Fax: (519) 900-2227 Electoral District: 04

Professional Corporation Information


Corporation Name: Woolfrey Medicine Professional Corporation
Certificate of Authorization Status: Issued Date:  Apr 19 2004

Shareholders:
Dr. M. Woolfrey ( CPSO# 63967 )
Dr. K. Woolfrey ( CPSO# 64112 )

Business Address:
270 King George Road
Brantford ON  N3R 5L5
Phone Number: (519) 900-5575

Business Address:
268 Grosvenor Street
London ON  N6A 4V2
Phone Number: (519) 646-6100

Business Address:
Brantford General Hospital
200 Terrace Hill Street
Brantford ON  N3R 1G9
Phone Number: (519) 751-5894

Business Address:
800 Commissioners Road East
London ON  N6A 5W9
Phone Number: (519) 685-8500

Business Address:
339 Windermere Road
London ON  N6A 5A5
Phone Number: (519) 685-8500


Medical Licences in Other Jurisdictions

Effective September 1, 2015, the College by-laws require the College to indicate on the register if the member has a licence or is registered to practise medicine in a jurisdiction outside Ontario, if this is known to the College.



USA - North Carolina

Hospital Privileges

Hospital Location
Brant Community Healthcare System Brantford

Specialties

Specialty Issued On Type
Orthopedic Surgery Effective:11 Sep 1997 RCPSC Specialist

Postgraduate Training

Please note: This information may not be a complete record of postgraduate training.



Schulich School of Medicine and Dentistr, 01 Jul 1995 to 30 Jun 1996
Resident 3 - Orthopedic Surgery

Schulich School of Medicine and Dentistr, 01 Jul 1996 to 30 Jun 1997
Resident 4 - Orthopedic Surgery

Schulich School of Medicine and Dentistr, 01 Oct 1997 to 30 Jun 1998
CF - Orthopedic Surgery

Schulich School of Medicine and Dentistr, 01 Jul 1998 to 30 Sep 1998
CF - Orthopedic Surgery

University of Ottawa, 01 Jan 2000 to 30 Jun 2000
CF - Orthopedic Surgery

Registration History

Action Issue Date
First certificate of registration issued: Postgraduate Education Certificate Effective: 15 Jun 1991
Expired: Terms and conditions of certificate of registration Expiry: 14 Jun 1992
Subsequent certificate of registration Issued: Independent Practice Certificate Effective: 27 Jun 1992
Transfer of class of certificate to: Restricted certificate Effective: 05 Jul 2017
Terms and conditions imposed on certificate by member Effective: 05 Jul 2017
Terms and conditions amended by member Effective: 02 Jul 2019

Practice Restrictions

Imposed By Effective Date Expiry Date Status
member Effective: 02 Jul 2019 Active
             (1 of 2)
            As  from  July  2,  2019,  the  following  is  imposed as terms, conditions and
            limitations  on the certificate of registration held  by  Dr.  Michael  Richard
            Woolfrey in accordance with an undertaking and consent given by Dr. Woolfrey to
            the College of Physicians and Surgeons of Ontario:

                        UNDERTAKING, ACKNOWLEDGEMENT AND CONSENT 
                                          ("Undertaking")
                  
                                                of
                  
                              DR. MICHAEL RICHARD WOOLFREY
                                          ("Dr. Woolfrey")
                  
                                                to 
                  
                        COLLEGE OF PHYSICIANS AND SURGEONS OF ONTARIO
                                          (the "College")
                  
                  
                  
            A.    PREAMBLE

            (1)   In this Undertaking:

                  "Code" means  the Health Professions Procedural Code, which is Schedule 2
                  to the Regulated  Health  Professions  Act,  1991,  S.O.  1991, c. 18, as
                  amended; 
                  
                  "OHIP" means the Ontario Health Insurance Plan;
                  
                  "Public Register" means the College's register that is available  to  the
                  public.
                  
            (2)   I, Dr. Woolfrey, certificate of registration number 63967, am a member of
                  the College.  

            (3)   I,  Dr.  Woolfrey,  acknowledge  that the College referred allegations of
                  professional  misconduct  to the Discipline  Committee  in  a  Notice  of
                  Hearing dated May 29, 2019.

            (4)   I, Dr. Woolfrey, acknowledge that, after the College receives an original
                  copy of this Undertaking as  signed  by me, the College will withdraw the
                  Notice of Hearing.  

            B.    UNDERTAKING

            (5)   I,  Dr.  Woolfrey,  undertake  to  abide  by   the   provisions  of  this
                  Undertaking, effective upon the date I sign it (the "Effective Date").

            (6)   Practice Restrictions

                  (a)   I, Dr. Woolfrey, undertake that I shall see a maximum of forty-five
                        (45) patients per day and a maximum of one hundred  and fifty (150)
                        patients per week, excluding patients seen while I am on-call.
                  
                  (b)   I, Dr. Woolfrey, undertake that I shall be on call no more than ten
                        (10) days every three (3) months and no more than thirty-seven (37)
                        days every year.
                  
                  (c)   I,  Dr. Woolfrey, undertake that I shall not perform injections  to
                        treat  chronic  pain.  For greater clarity, I understand that I may
                        perform injections  to treat new acute indications, and may perform
                        aspirations for inflammatory/arthritic conditions of joints, bursa,
                        cysts,   ligaments,   or   tendons,   aspirations   to   rule   out
                        infection/inflammatory   conditions   of   joints,   bursa,  cysts,
                        abscesses,  ligaments,  or  tendons,  and injections for anesthetic
                        purposes for procedures.
                  
                  (d)   I, Dr. Woolfrey, undertake that I shall  not provide counseling for
                        chronic pain nor bill OHIP for counseling for chronic pain.
                  
            (7)   Clinical Supervision 

                  (a)   I,  Dr. Woolfrey, undertake to practise under  the  guidance  of  a
                        clinical  supervisor  or  clinical  supervisors  acceptable  to the
                        College (the "Clinical Supervisor" or "Clinical Supervisors"),  for
                        twelve (12) months ("Clinical Supervision"). 
                  
                  (b)   I,  Dr.  Woolfrey,  undertake  that  during  the period of Clinical
                        Supervision  I shall keep a log of all joint injections  performed,
                        including the  date,  patient  identifier and type of injection, to
                        facilitate review by my Clinical Supervisor.
                  
                  (c)   I, Dr. Woolfrey, acknowledge that  I  have  reviewed  the  Clinical
                        Supervisor's  undertaking,  attached  hereto  as  Appendix "A", and
                        understand  what  is  required  of  the  Clinical  Supervisor.  The
                        Clinical Supervisor will, at minimum: 
                  
                        (i)   Facilitate   the   education   program   set   out   in   the
                              Individualized  Education  Plan  ("IEP"),  attached hereto as
                              Appendix "B";
                  
                        (ii)  Review  the  materials provided by the College  and  have  an
                              initial   meeting    to    discuss    practice    improvement
                              recommendations;
                  
                        (iii) Meet  with  me  at  my Practice Location, or another location
                              approved by the College,  once  every  month  for  three  (3)
                              months and once every quarter for nine (9) months thereafter;
                  
                        (iv)  Review  at  least  fifteen (15) of my patient charts at every
                              meeting,  including the  charts  of  every  patient  who  has
                              received arthroscopy  and  a  selection of those patients who
                              have received injections;
                  
                        (v)   Discuss any concerns arising from the chart reviews;
                  
                        (vi)  Make  recommendations  to me for  practice  improvements  and
                              ongoing  professional  development   and   inquire   into  my
                              compliance with the recommendations; 
                  
                        (vii) Perform  any  other duties, such as reviewing other documents
                              or conducting interviews  with  staff or colleagues, that the
                              Clinical   Supervisor   deems  necessary   to   my   Clinical
                              Supervision; and
                  
                        (viii)Submit written reports to  the  College  at  least once every
                              month  for three (3) months and once every quarter  for  nine
                              (9) months  thereafter,  or  more  frequently if the Clinical
                              Supervisor has concerns about my standard of practice.
                  
                  (d)   I,  Dr.  Woolfrey, acknowledge that the charts  reviewed  shall  be
                        selected by  the  Clinical Supervisor based on the criteria set out
                        above, the educational  needs identified in the IEP attached hereto
                        as Appendix "B", as well  as the areas of concern identified in the
                        reports of the medical inspector  dated  June 2, 2018, July 2, 2018
                        and  September 25, 2018, and concerns that  may  arise  during  the
                        period of Clinical Supervision.
                  
                  (e)   I, Dr.  Woolfrey,  undertake  to  cooperate fully with the Clinical
                        Supervision  of  my practice, conducted  under  the  term  of  this
                        Undertaking and Appendix  "A"  to this Undertaking, and to abide by
                        the recommendations of my Clinical  Supervisor,  including  but not
                        limited  to,  any  recommended  practice  improvements  and ongoing
                        professional development.
                  
                  (f)   I,  Dr.  Woolfrey,  undertake  to ensure that Appendix "A" to  this
                        Undertaking is signed and delivered  to  the  College within thirty
                        (30) days of the Effective Date.
                  
                  (g)   I,  Dr.  Woolfrey,  undertake  that if a person who  has  given  an
                        undertaking  in  Appendix  "A" to this  Undertaking  is  unable  or
                        unwilling to continue to fulfill  its  provisions,  I shall, within
                        twenty  (20) days of receiving notice of same, obtain  an  executed
                        undertaking  in the same form from a similarly qualified person who
                        is acceptable to the College and ensure that it is delivered to the
                        College within that time.
                  
                  (h)   I, Dr. Woolfrey, undertake that if I am unable to obtain a Clinical
                        Supervisor on  the  provisions set out under sections (6)(f) and/or
                        (g) above, I will cease  practising  medicine  until such time as I
                        have obtained a Clinical Supervisor acceptable to the College.  
                  
                        (i)   I, Dr. Woolfrey, acknowledge that if I am  required  to cease
                              practise  as  a  result  of  section  (6)(h)  above this will
                              constitute a term, condition or limitation on my  certificate
                              of  registration and that term, condition or limitation  will
                              be included on the public register.
                  
            (8)   Professional Education  

                  (a)   I, Dr. Woolfrey,  undertake to successfully complete all aspects of
                        the detailed IEP, attached hereto as Appendix "B", including all of
                        the   following   professional    education    (the   "Professional
                        Education"):
                  
                        (i)   University of Toronto Faculty of Medicine  program in Medical
                              Record-Keeping:  http://www.cpd.utoronto.ca/recordkeeping/;
                  
                        (ii)  CMPA  e-learning  modules:  Documentation:  Charting  Medical
                              Records  and  Documentation II: Principles of Medical  Record
                              Keeping; 
                  
                        (iii) PROBE: Ethics &  Boundaries  Program,  by receiving a passing
                              evaluation or grade, without any condition  or qualification,
                              and
                  
                        (iv)  a written summary of approximately 2-4 pages or 2000 words of
                              the following resources:
                  
                              1.    CPSO          Policy         "Medical         Records":
                                    https://www.cpso.on.ca/Policies-Publications/Policy/Medical-Records;
                  
                              2.    Clinical   Practice    Guideline:    Indications    for
                                    Arthroscopy in Patients with Osteoarthritis; and
                  
                        (v)   any  additional  professional  education  recommended  by  my
                              Clinical Supervisor.
                  
                  (b)   I,  Dr.  Woolfrey,  undertake to provide proof to the College of my
                        successful completion  of  the  Professional  Education,  including
                        proof  of  registration  and  attendance and participant assessment
                        reports where relevant, within  one  (1)  month of completing it. I
                        acknowledge  that  the  College  will  determine,   in   its   sole
                        discretion,  whether I have successfully completed the Professional
                        Education.
                  
                  (c)   I, Dr. Woolfrey, undertake to complete this requirement by December
                        31, 2019 or, if  no satisfactory program is available by that time,
                        by the first possible opportunity thereafter.
                  
                  (d)   I, Dr. Woolfrey, acknowledge  that  a  report  or  reports  may  be
                        provided  to  the College regarding my progress and compliance with
                        the Professional Education.
                  
            (9)   Reassessment of Practice

                  (a)   I, Dr. Woolfrey, undertake that, approximately six (6) months after
                        the completion  of  the Clinical Supervision set out in section (6)
                        above and Appendix "A"  to  this  Undertaking,  I  will submit to a
                        reassessment of my practice ("the Reassessment") by  an assessor or
                        assessors  selected by the College (the "Assessor" or "Assessors").
                        I acknowledge  that  the  Reassessment  may include a chart review,
                        direct  observation  of  my care, interviews  with  colleagues  and
                        co-workers, feedback from  patients  and  any  other  tools  deemed
                        necessary by the College.
                  
                  (b)   I,   Dr.   Woolfrey,   undertake   to  co-operate  fully  with  the
                        Reassessment, conducted under the term of this Undertaking. 
                  
                  (c)   I,  Dr.  Woolfrey,  acknowledge  that my  Clinical  Supervisor  may
                        receive and review the findings of  the  Assessor,  and may discuss
                        with  the  Assessor  any  issues  or  concerns  arising  from   the
                        Reassessment. 
                  
                  (d)   I,  Dr.  Woolfrey, acknowledge that the results of the Reassessment
                        will be provided  to  me  and  reported  to  the  College  and  the
                        Reassessment may form the basis of further action by the College. 
                  
            (10)  Monitoring 

                  (a)   I,  Dr. Woolfrey, undertake to inform the College of each and every
                        location  that  I  practise  or have privileges, including, but not
                        limited to, any hospitals, clinics,  offices,  and  any Independent
                        Health  Facilities with which I am affiliated, in any  jurisdiction
                        (collectively  my  "Practice  Location"  or  "Practice Locations"),
                        within five (5) days of executing this Undertaking.  Going forward,
                        I  further  undertake  to  inform the College of any  and  all  new
                        Practice Locations within five  (5)  days of commencing practice at
                        that location.
                  
                  (b)   I, Dr. Woolfrey, undertake that I will submit to, and not interfere
                        with, unannounced inspections of my Practice  Locations and patient
                        records by a College representative for the purposes  of monitoring
                        my compliance with the provisions of this Undertaking.
                  
                  (c)   I, Dr. Woolfrey, give my irrevocable consent to the College to make
                        appropriate enquiries of OHIP and/or any person who or  institution
                        that  may  have  relevant information, in order for the College  to
                        monitor my compliance with the provisions of this Undertaking. 
                  
                  (d)   I, Dr. Woolfrey, acknowledge  that I have executed the OHIP consent
                        form attached hereto as Appendix "C". 
                  
            C.    ACKNOWLEDGEMENT

            (11)  I, Dr. Woolfrey, acknowledge that all  appendices attached to or referred
                  to in this Undertaking form part of this Undertaking.

            (12)  I,  Dr.  Woolfrey,  acknowledge and undertake  that  I  shall  be  solely
                  responsible for payment  of  all  fees,  costs,  charges,  expenses, etc.
                  arising  from  the  implementation  of  any  of  the  provisions of  this
                  Undertaking. 

            (13)  I,  Dr.  Woolfrey,  acknowledge  that  I  have  read  and understand  the
                  provisions of this Undertaking and that I have obtained independent legal
                  counsel in reviewing and executing this Undertaking, or  have  waived  my
                  right to do so.

            (14)  I,   Dr.  Woolfrey,  acknowledge  that  the  College  will  provide  this
                  Undertaking   to  any  Chief  of  Staff,  or  a  colleague  with  similar
                  responsibilities,  at  any Practice Location ("Chief of Staff" or "Chiefs
                  of Staff").

            (15)  I, Dr. Woolfrey, acknowledge that a breach by me of any provision of this
                  Undertaking may constitute  an  act  of  professional  misconduct  and/or
                  incompetence,  and  may result in a referral of specified allegations  to
                  the Discipline Committee of the College.

            (16)  I, Dr. Woolfrey, acknowledge  that  this  Undertaking  constitutes terms,
                  conditions,  and  limitations on my certificate of registration  for  the
                  purposes of section 23 of the Code. 

            (17)  Public Register

                  (a)   I, Dr. Woolfrey, acknowledge that, during the time period that this
                        Undertaking remains  in effect, this Undertaking shall be posted on
                        the Public Register.
                  
                  (b)   I, Dr. Woolfrey, acknowledge  that, in addition to this Undertaking
                        being  posted  in  accordance  with   section  (17)(a)  above,  the
                        following summary shall be posted on the Public Register during the
                        time period that this Undertaking remains in effect:
                  
                              Dr.  Woolfrey  was referred to the  Discipline  Committee  on
                              allegations of professional  misconduct.  In exchange for Dr.
                              Woolfrey's agreement to the restrictions  set  out below, the
                              College withdrew the Notice of Hearing.
                  
                              Dr. Woolfrey shall see a maximum of 45 patients per day and a
                              maximum  of  150  patients per week, excluding patients  seen
                              while he is on-call.
                  
                              Dr. Woolfrey shall  be  on  call  no  more than 10 days every
                              three months and no more than 37 days every year. 
                  
                              Dr. Woolfrey shall not perform injections  to  treat  chronic
                              pain,   but   may   perform   injections  for  certain  other
                              indications as specified in the Undertaking.
                  
                              Dr. Woolfrey shall not provide  counseling  for  chronic pain
                              and shall not bill OHIP for counseling for chronic pain. 
                  
                              Dr.  Woolfrey will practise under the guidance of a  Clinical
                              Supervisor acceptable to the College for 12 months. 
                  
                              Dr. Woolfrey will engage in professional education in medical
                              record-keeping, certain clinical guidelines, and ethics.
                  
                              Dr. Woolfrey's  practice  will  be  reassessed by an assessor
                              selected by the College approximately  6 months after the end
                              of the period of Clinical Supervision.
                  
            D.    CONSENT

            (18)  I, Dr. Woolfrey, give my irrevocable consent to the  College  to  provide
                  the following information to any person who requires this information for
                  the  purposes of facilitating my completion of the Professional Education
                  and to all Clinical Supervisors, and/or Assessors:

                  (a)   any information the College has that led to the circumstances of my
                        entering into this Undertaking;
                  
                  (b)   any  information arising from any investigation into, or assessment
                        of, my practice; and 
                  
                  (c)   any information  arising  from the monitoring of my compliance with
                        this Undertaking.
                  
            (19)  I, Dr. Woolfrey, give my irrevocable  consent  to  the College to provide
                  all Chiefs of Staff with any information the College  has that led to the
                  circumstances of my entering into this Undertaking and/or any information
                  arising from the monitoring of my compliance with this Undertaking.

            (20)  I,  Dr.  Woolfrey,  give  my  irrevocable  consent  to  any  persons  who
                  facilitate  my  completion  of  the  Professional  Education, and to  all
                  Clinical Supervisors, Chiefs of Staff and Assessors,  to  disclose to the
                  College, and to one another, any of the following:

                  (a)   any information relevant to this Undertaking;
                  
                  (b)   any   information  relevant  to  the  provisions  of  the  Clinical
                        Supervisor's   undertaking   set   out  at  Appendix  "A"  to  this
                        Undertaking;
                  
                  (c)   any information relevant to the Reassessment;
                  
                  (d)   any  information  relevant  for  the  purposes   of  monitoring  my
                        compliance with this Undertaking; and/or  
                  
                  (e)   any  information which comes to their attention in  the  course  of
                        providing  the  Professional  Education  and  which they reasonably
                        believes indicates a potential risk of harm to my patients.
                  
                  
                  
            (2 of 2)
            As  from  July  5,  2017,  the  following  is imposed as a term, condition  and
            limitation  on the certificate of registration  held  by  Dr.  Michael  Richard
            Woolfrey, in  accordance  with an undertaking and consent given by Dr. Woolfrey
            to the College of Physicians and Surgeons of Ontario:

                        UNDERTAKING, ACKNOWLEDGEMENT AND CONSENT 
                                          ("Undertaking")
                  
                                                of
                  
                              DR. MICHAEL RICHARD WOOLFREY
                                          ("Dr. Woolfrey")
                  
                                                to 
                  
                        COLLEGE OF PHYSICIANS AND SURGEONS OF ONTARIO
                                          (the "College")
                  
                  
                  
                  
            A.    PREAMBLE

            (1)   In this Undertaking:

                  "Code" means the Health  Professions Procedural Code, which is Schedule 2
                  to the Regulated Health Professions  Act,  1991,  S.O.  1991,  c.  18, as
                  amended; 
                  
                  "ICR Committee" means the Inquiries, Complaints and Reports Committee  of
                  the College.
                  
                  "Narcotic  Drugs"  means from the Narcotic Control Regulations made under
                  the Controlled Drugs and Substances Act, S.C., 1996, c. 19, as amended.
                  
                  "Narcotic Preparations"  means from the Narcotic Control Regulations made
                  under the Controlled Drugs  and  Substances  Act,  S.C.,  1996, c. 19, as
                  amended.
                  
                  "Controlled  Drugs"  means  from  Part G of the Food and Drug Regulations
                  under the Food and Drugs Act, S.C., 1985, c. F-27, as amended.
                  
                  "Benzodiazepines  and  Other  Targeted   Substances"   means   from   the
                  Benzodiazepines  and Other Targeted Substances Regulations made under the
                  Controlled Drugs and Substances Act., S.C., 1996, c. 19, as amended 
                  
                  (A summary of the above-named drugs [from Appendix I to the Compendium of
                  Pharmaceuticals and  Specialties] is attached hereto as Schedule "A"; and
                  the current regulatory lists are attached hereto as Schedule "B")
                  
                  "All other Monitored Drugs"  means  as defined under the Narcotics Safety
                  and  Awareness Act, 2010, S.O. 2010, c.  22,  as  amended,  as  noted  in
                  Schedule "C".                                                
                  
                  "NMS"  means  the  Drug Program Services Branch, the Narcotics Monitoring
                  System implemented under  the  Narcotics  Safety and Awareness Act, 2010,
                  S.O. 2010, c. 22, as amended;
                  
                  "OHIP" means the Ontario Health Insurance Plan;
                  
                  "Public Register" means the College's register  that  is available to the
                  public.
                  
            (2)   I, Dr. Woolfrey, certificate of registration number 63967, am a member of
                  the College.  

            (3)   I, Dr. Woolfrey, acknowledge that the College received  information  from
                  the  NMS  and initiated an investigation bearing File Number 7215641 (the
                  "Investigation")  into  whether  I  failed  to  maintain  the standard of
                  practice  of  the  profession and/or am incompetent in my prescribing  of
                  controlled substances, including narcotics.

            B.    UNDERTAKING

            (4)   I, Dr. Woolfrey, undertake to abide by the provisions of this Undertaking
                  effective immediately upon the signing of this Undertaking.

            (5)   Practice Restriction, Prescribing Log and Copies of Prescriptions

                  (a)   I, Dr. Woolfrey,  undertake  that  I  shall  not prescribe Narcotic
                        Drugs, Narcotic Preparations, Controlled Drugs, Benzodiazepines and
                        Other Targeted Substances and All other Monitored Drugs for chronic
                        non-cancer pain.
                  
                  (b)   Notwithstanding paragraph (5)(a), I, Dr. Woolfrey, may:
                  
                        i.    prescribe the above-noted medications for  acute post-injury,
                              post-fracture or post-surgical pain; and 
                  
                        ii.   write  hospital  orders  for the above-noted medications  for
                              hospital in-patients during  the  course  of their in-patient
                              stay to be dispensed through the hospital pharmacy only.
                  
            (6)   I,  Dr.  Woolfrey,  shall  keep a log of all prescriptions  for  Narcotic
                  Drugs, Narcotic Preparations, Controlled Drugs, Benzodiazepines and Other
                  Targeted Substances and All  other  Monitored  Drugs,  excluding hospital
                  orders for these medications made in accordance with paragraph (5)(b)(ii)
                  of  this  Undertaking, in the form attached as set out in  Schedule  "D",
                  which will  include  at least the following information (the "Prescribing
                  Log"):  

                        (i)   the date of the patient encounter;
                        (ii)  the name of the patient and chart/file number;
                        (iii) the  name of  the  medication  prescribed,  dose,  direction,
                              number of tablets to be dispensed and frequency;
                        (iv)  the clinical indication;
                        (v)   whether  Dr.  Woolfrey  has prescribed this medication and/or
                              another Narcotic Drug, Narcotic Preparation, Controlled Drug,
                              Benzodiazepine or Other Targeted  Substance  to  this patient
                              for a consecutive duration exceeding three (3) months (Y/N); 
                        (vi)  Dr. Woolfrey's signature;
                        (vii) the  date of the Clinical Supervisor's review (if applicable,
                              as set out below); and
                        (viii)the Clinical  Supervisor's  signature  (if applicable, as set
                              out below).
                  
            (7)   I,  Dr. Woolfrey, undertake to keep a copy of all prescriptions  I  write
                  for   Narcotic    Drugs,   Narcotic   Preparations,   Controlled   Drugs,
                  Benzodiazepines and  Other  Targeted  Substances  and All other Monitored
                  Drugs, in the corresponding patient chart.

            (8)   Clinical Supervision

                  (a)   I,  Dr. Woolfrey, undertake to practise under  the  guidance  of  a
                        clinical  supervisor(s)  acceptable  to  the College (the "Clinical
                        Supervisor(s)"), for a minimum of nine (9)  months on the terms set
                        out below (the "Clinical Supervision"). 
                  
                  (b)   I,  Dr.  Woolfrey,  acknowledge that the purpose  of  the  Clinical
                        Supervision is to ensure  that  I am in compliance with my Practice
                        Restriction as set out at paragraph  5 of this Undertaking and that
                        my prescribing of Narcotic Drugs, Narcotic Preparations, Controlled
                        Drugs, Benzodiazepines and Other Targeted  Substances and All other
                        Monitored   Drugs   for   acute   post-injury,   post-fracture   or
                        post-surgical pain is appropriate.
                  
                  (c)   I,  Dr.  Woolfrey,  acknowledge  and undertake that each  phase  of
                        Clinical  Supervision  set out below  will  only  be  reduced  upon
                        recommendation of the Clinical  Supervisor(s)  and  approval by the
                        College.
                  
                  Phase 1 of Clinical Supervision ("Phase 1")
                  
                  (d)   I,  Dr.  Woolfrey,  undertake  to  engage  in  Phase  1 of Clinical
                        Supervision for a minimum of three (3) months on the terms  set out
                        below.
                  
                  (e)   During Phase 1, I, Dr. Woolfrey, undertake to meet with my Clinical
                        Supervisor(s)  at  least  once  every month to discuss the Clinical
                        Supervisor(s)'s review of:
                  
                        i.    15 charts for patients to whom  I  have  prescribed  Narcotic
                              Drugs,     Narcotic     Preparations,    Controlled    Drugs,
                              Benzodiazepines and Other  Targeted  Substances and All other
                              Monitored  Drugs  since  the  Clinical Supervisor(s)'s  prior
                              review,  or  if  there  are not 15  patients  listed  in  the
                              Prescribing  Log  since the  Clinical  Supervisor(s)'s  prior
                              review,  then  the charts  of  all  patients  listed  in  the
                              Prescribing Log since the Clinical Supervisor's prior review;
                              and
                  
                        ii.   the chart of every  patient  to  whom  I  have  prescribed  a
                              Narcotic   Drug,   Narcotic   Preparation,  Controlled  Drug,
                              Benzodiazepine  and/or Other Targeted  Substance  and/or  any
                              other Monitored Drug  for  a  consecutive  duration exceeding
                              three (3) months.
                  
                  (f)   I,  Dr.  Woolfrey,  acknowledge that during Phase 1,  the  Clinical
                        Supervisor(s) must sign and date the Prescribing Log to confirm the
                        charts that the Clinical  Supervisor(s) have reviewed and discussed
                        with me;
                  
                  (g)   I, Dr. Woolfrey, acknowledge  that  during  Phase  1,  the Clinical
                        Supervisor(s)  will  provide a report to the College at least  once
                        every month.
                  
                  (h)   I, Dr. Woolfrey, acknowledge  that  after  a  minimum  of three (3)
                        months of Phase 1, if the Clinical Supervisor(s) is satisfied  that
                        I have the necessary knowledge, skills and judgment to practice  in
                        a  less  highly  supervised environment, the Clinical Supervisor(s)
                        may recommend to the College that supervision be reduced. 
                  
                  
                  Phase 2 of Clinical Supervision ("Phase 2")
                  
                  (i)   Upon the recommendation  of the Clinical Supervisor(s) and approval
                        by the College, I, Dr. Woolfrey,  undertake to engage in Phase 2 of
                        Clinical Supervision for a minimum  of  six (6) months on the terms
                        set out below.
                  
                  (j)   During Phase 2, I, Dr. Woolfrey, undertake to meet with my Clinical
                        Supervisor(s) at least once every three (3)  months  to discuss the
                        Clinical Supervisor(s)'s review of:
                  
                        i.    15  charts  for  patients to whom I have prescribed  Narcotic
                              Drugs,    Narcotic    Preparations,     Controlled     Drugs,
                              Benzodiazepines  and  Other Targeted Substances and All other
                              Monitored  Drugs  since the  Clinical  Supervisor(s)'s  prior
                              review,  or if there  are  not  15  patients  listed  in  the
                              Prescribing  Log  since  the  Clinical  Supervisor(s)'s prior
                              review,  then  the  charts  of  all  patients listed  in  the
                              Prescribing Log since the Clinical Supervisor's prior review;
                              and
                  
                        ii.   the  chart  of  every  patient  to whom I have  prescribed  a
                              Narcotic   Drug,  Narcotic  Preparation,   Controlled   Drug,
                              Benzodiazepine  and/or  Other  Targeted  Substance and/or any
                              other  Monitored  Drug  for a consecutive duration  exceeding
                              three (3) months. 
                  
                  (k)   I, Dr. Woolfrey, acknowledge that  during  Phase  2,  the  Clinical
                        Supervisor(s) must sign and date the Prescribing Log to confirm the
                        charts  that the Clinical Supervisor(s) have reviewed and discussed
                        with me.
                  
                  (l)   I, Dr. Woolfrey,  acknowledge  that  during  Phase  2, the Clinical
                        Supervisor(s)  will provide a report to the College at  least  once
                        every three (3) months.
                  
                  (m)   I, Dr. Woolfrey, acknowledge that after a minimum of six (6) months
                        of Phase 2, if the  Clinical Supervisor(s) is satisfied that I have
                        the necessary knowledge,  skills  and  judgment to practice without
                        supervision,  the  Clinical  Supervisor(s)  may  recommend  to  the
                        College that the Clinical Supervision cease.
                  
                  (n)   I,  Dr.  Woolfrey,  acknowledge and  undertake  that  the  Clinical
                        Supervision will only  cease  upon  recommendation  of the Clinical
                        Supervisor(s) and approval by the College.
                  
                  (o)   I,  Dr.  Woolfrey,  acknowledge  that I have reviewed the  Clinical
                        Supervisor(s)'s undertaking, attached  hereto  as Schedule "E", and
                        understand  what  is  required  of the Clinical Supervisor(s).   In
                        addition to what is set out above, the Clinical Supervisor(s) will,
                        at a minimum: 
                  
                        (i)   Facilitate   the   education   program   set   out   in   the
                              Individualized Education Plan ("IEP")  attached  as  Schedule
                              "F";
                  
                        (ii)  Discuss  any concerns with me arising from chart reviews  and
                              observations;
                  
                        (iii) Make recommendations  to  me  for  practice  improvements and
                              ongoing   professional   development  and  inquire  into   my
                              compliance with the recommendations; and
                  
                        (iv)  Perform any other duties,  such  as reviewing other documents
                              or conducting interviews with staff  or  colleagues, that the
                              Clinical   Supervisor(s)   deem  necessary  to  my   Clinical
                              Supervision.
                  
                  (p)   I,  Dr.  Woolfrey, undertake that all  meetings  with  my  Clinical
                        Supervisor(s)  will  take place at my Practice Location, or another
                        location approved by the College;
                  
                  (q)   I, Dr. Woolfrey, acknowledge  that  all  charts  reviewed  shall be
                        independently  selected by the Clinical Supervisor(s) based on  the
                        educational needs  identified in the IEP set out at Schedule "F" to
                        my Undertaking, as well  as  the areas of concern identified in the
                        report  of  the medical inspector  dated  February  21,  2017,  and
                        concerns that may arise during the period of Clinical Supervision.
                  
                  (r)   I, Dr. Woolfrey,  undertake  to  cooperate  fully with the Clinical
                        Supervision  of  my  practice, conducted under the  terms  of  this
                        Undertaking  and  Schedule  "E"  attached,  and  to  abide  by  the
                        reasonable recommendations  of my Clinical Supervisor(s), including
                        but   not   limited   to,  any  reasonable   recommended   practice
                        improvements and ongoing professional development.
                  
                  (s)   I, Dr. Woolfrey, undertake  to  ensure  that  Schedule  "E" to this
                        Undertaking,  is signed and delivered to the College within  thirty
                        (30) days of the Effective Date.
                  
                  (t)   I, Dr. Woolfrey,  undertake  that  if  a  person  who  has given an
                        undertaking  in  Schedule  "E"  to  this  Undertaking is unable  or
                        unwilling to continue to fulfill its provisions,  I  shall,  within
                        thirty  (30)  days  of receiving notice of same, obtain an executed
                        undertaking in the same  form from a similarly qualified person who
                        is acceptable to the College and ensure that it is delivered to the
                        College within that time.
                  
                  (u)   I, Dr. Woolfrey, agree that  if  I  am  unable to obtain a Clinical
                        Supervisor  on  the  terms set out in sections  (8)(s)  and/or  (t)
                        above,   I  will  cease  prescribing   narcotic   drugs,   narcotic
                        preparations,  controlled drugs, benzodiazepines and other targeted
                        substances, and all other monitored drugs until such time as I have
                        obtained a Clinical Supervisor acceptable to the College.  
                  
                  (v)   I, Dr. Woolfrey,  agree  that if I am required to cease prescribing
                        narcotic   drugs,   narcotic   preparations,    controlled   drugs,
                        benzodiazepines  and  other  targeted  substances,  and  all  other
                        monitored  drugs  as  a  result  of section (8)(u) above this  will
                        constitute a term, condition or limitation  on  my  certificate  of
                        registration  and  that  term,  condition  or  limitation  will  be
                        included on the Public Register.
                  
            (9)   Professional Education  

                  (a)   In  the  course of this investigation, I, Dr. Woolfrey, voluntarily
                        enrolled in  the  University of Toronto Faculty of Medicine program
                        in  Safe  Opioid Prescribing  (all  three  webinars  and  in-person
                        workshop): www.cepd.utoronto.ca/opioidprescribing;
                  
                  (b)   I, Dr. Woolfrey,  undertake  to  participate  in  and  successfully
                        complete  all  elements  of  the  detailed IEP, attached hereto  as
                        Schedule "F", including but not limited  to, the following elements
                        of professional education (the "Professional Education"):
                  
                        (i)   University  of Toronto Faculty of Medicine  program  in  Safe
                              Opioid  Prescribing   (all   three   webinars  and  in-person
                              workshop): www.cepd.utoronto.ca/opioidprescribing;
                  
                        (ii)  Review  and  discuss  with  my  Clinical  Supervisor(s)   the
                              following resources:
                  
                              1.    CPSO         Policy         "Prescribing        Drugs":
                                    http://www.cpso.on.ca/Policies-Publications/Policy/Prescribing-Drugs;
                  
                              2.    2017  Canadian  Guideline  for  Opioids   for   Chronic
                                    Non-Cancer                                        Pain:
                                    http://nationalpaincentre.mcmaster.ca/guidelines.html;
                  
                              3.    CMPA  advice regarding preventing the misuse of opioids
                                    https://www.cmpa-acpm.ca/en/advice-publications/browse-articles/2015/preventing-the-misuse-of-opioids;
                                    and
                  
                        (iii) any  additional  professional  education  recommended  by  my
                              Clinical Supervisor(s).
                  
                  (c)   I, Dr. Woolfrey,  undertake  to  provide proof to the College of my
                        successful completion of each element of the Professional Education
                        specified above, including proof of  registration,  attendance  and
                        participant  assessment  reports  where  available,  within one (1)
                        month of completion of each element. I acknowledge that the College
                        will determine, in its sole discretion, whether I have successfully
                        completed each element of the Professional Education.
                  
                  (d)   I,  Dr.  Woolfrey,  acknowledge  that  a report or reports  may  be
                        provided to the College regarding my progress  and  compliance with
                        the Professional Education.
                  
            (10)  Reassessment of Practice

                  (a)   I,  Dr.  Woolfrey,  undertake  that,  approximately six (6)  months
                        after  the Clinical Supervision set out  under  section  8  of  the
                        Undertaking  has  ceased,  I  will  submit  to a reassessment of my
                        practice by an assessor or assessors selected  by  the College (the
                        "Reassessment").

                  (b)   I,  Dr.  Woolfrey,  acknowledge  and  agree that the focus  of  the
                        Reassessment shall be on ensuring that  I  am in compliance with my
                        Practice Restriction as set out at paragraph  5 of this Undertaking
                        and  that my prescribing of Narcotic Drugs, Narcotic  Preparations,
                        Controlled Drugs, Benzodiazepines and Other Targeted Substances and
                        All other  Monitored  Drugs for acute post-injury, post-fracture or
                        post-surgical pain is appropriate.
                  
                  (c)   I, Dr. Woolfrey, acknowledge  and  agree  that the Reassessment may
                        include a chart review, direct observation of my care, an interview
                        of  me,  interviews with colleagues and co-workers,  feedback  from
                        patients and any other tools deemed necessary by the College.
                  
                  (d)   I,  Dr.  Woolfrey,   undertake   to   co-operate   fully  with  the
                        Reassessment, conducted under the terms of this Undertaking 
                  
                  (e)   I,   Dr.   Woolfrey,   acknowledge   and  agree  that  my  Clinical
                        Supervisor(s)  may  receive  and  review  the   findings   of   the
                        Assessor(s),  and  may  discuss  with the Assessor(s) any issues or
                        concerns arising from the Reassessment.  
                  
                  (f)   I, Dr. Woolfrey, acknowledge that  the  results of the Reassessment
                        will be provided to me and reported to the  College  and  that  the
                        Reassessment may form the basis of further action by the College.
                  
            (11)  Monitoring 

                  (a)   I,  Dr. Woolfrey, undertake to inform the College of each and every
                        location at which I practise or have privileges, including, but not
                        limited   to,   hospital(s),   clinic(s)   and  office(s),  in  any
                        jurisdiction (collectively my "Practice Location(s)"),  within  ten
                        (10) business days of executing this Undertaking.  Going forward, I
                        further undertake to inform the College of any and all new Practice
                        Locations  within  ten (10) business days of commencing practice at
                        that location.
                  
                  (b)   I, Dr. Woolfrey, undertake and agree that I will submit to, and not
                        interfere with, unannounced  inspections of my Practice Location(s)
                        and patient records by a College representative for the purposes of
                        monitoring my compliance with the provisions of this Undertaking.
                  
                  (c)   I, Dr. Woolfrey, give my irrevocable consent to the College to make
                        appropriate  enquiries  of  the  Ontario   Health   Insurance  Plan
                        ("OHIP"),   the   Drug   Program  Services  Branch,  the  Narcotics
                        Monitoring System ("NMS")  implemented  under  the Narcotics Safety
                        and  Awareness Act, 2010 and/or any person or institution  who  may
                        have relevant  information,  in order for the College to monitor my
                        compliance with the provisions of this Undertaking. 
                  
                  (d)   I, Dr. Woolfrey, acknowledge that  I have executed the OHIP and NMS
                        consent form(s), attached hereto as  Schedule "G" and Schedule "H",
                        respectively. 
                  
            C.    ACKNOWLEDGEMENT

            (12)  I, Dr. Woolfrey, acknowledge that all schedules  attached  to or referred
                  to in this Undertaking form part of this Undertaking.

            (13)  I,  Dr.  Woolfrey,  acknowledge  that  I shall be solely responsible  for
                  payment  of all fees, costs, charges, expenses,  etc.  arising  from  the
                  implementation of any of the provisions of this Undertaking. 

            (14)  I, Dr. Woolfrey,  acknowledge and confirm that I have read and understand
                  the provisions of this  Undertaking  and that I have obtained independent
                  legal counsel in reviewing and executing this Undertaking, or have waived
                  my right to do so.

            (15)  I,  Dr.  Woolfrey,  acknowledge  that  the   College  will  provide  this
                  Undertaking  to  any  Chief  of  Staff,  or  a  colleague   with  similar
                  responsibilities, at any Practice Location ("Chief(s) of Staff").

            (16)  I, Dr. Woolfrey, acknowledge that a breach by me of any provision of this
                  Undertaking  may  constitute  an  act  of professional misconduct  and/or
                  incompetence, and may result in a referral  of  specified  allegations to
                  the Discipline Committee of the College.

            (17)  I,  Dr.  Woolfrey,  acknowledge  that this entire Undertaking constitutes
                  terms, conditions, and limitations  on my certificate of registration for
                  the purposes of section 23 of the Code. 

            (18)  Public Register

                  (a)   I, Dr. Woolfrey, acknowledge that, during the time period that this
                        Undertaking remains in effect,  this Undertaking shall be posted on
                        the Public Register.
                  
                  (b)   I, Dr. Woolfrey, acknowledge that,  in addition to this Undertaking
                        being posted in accordance with the section  above,  the  following
                        summary  shall  be  posted  on  the Public Register during the time
                        period that this Undertaking remains in effect:
                  
                        The  College received information  from  the  Narcotics  Monitoring
                        System  about  Dr. Woolfrey's prescribing of controlled substances,
                        including narcotics.
                  
                        Based  on  the  information  received,  the  College  conducted  an
                        investigation into  whether  Dr.  Woolfrey  failed  to maintain the
                        standard  of  practice of the profession and/or was incompetent  in
                        his prescribing  of controlled substances, including narcotics.  As
                        a result of the investigation:
                  
                        Dr.  Woolfrey  shall   not   prescribe   Narcotic  Drugs,  Narcotic
                        Preparations, Controlled Drugs, Benzodiazepines  and Other Targeted
                        Substances  and  All  other Monitored Drugs for chronic  non-cancer
                        pain.
                  
                        Notwithstanding this restriction, Dr. Woolfrey may:
                  
                              prescribe the above-noted  medications for acute post-injury,
                              post fracture or post-surgical pain; and 
                  
                              write  hospital orders for the  above-noted  medications  for
                              hospital  in-patients  during  the course of their in-patient
                              stay to be dispensed through the hospital pharmacy only.
                  
                              Dr.  Woolfrey's  prescribing  of  narcotic   drugs,  narcotic
                              preparations,  controlled  drugs, benzodiazepines  and  other
                              targeted  substances,  and  other  monitored  drugs  will  be
                              supervised by a Clinical Supervisor acceptable to the College
                              for a minimum of nine (9) months. 
                  
                              Dr.  Woolfrey will engage in professional  education  in  the
                              prescribing of controlled substances, including narcotics.
                  
                              Following   the   professional   education   and   period  of
                              supervision,   Dr.   Woolfrey's   prescribing  of  controlled
                              substances, including narcotics, will  be  re-assessed  by an
                              assessor selected by the College.
                  
            D.    CONSENT

            (19)  I,  Dr.  Woolfrey,  give my irrevocable consent to the College to provide
                  the following information to any person who requires this information for
                  the purposes of facilitating  my completion of the Professional Education
                  and to all Clinical Supervisors, and/or Assessors:

                  (a)   any information the College has that led to the circumstances of my
                        entering into this Undertaking;
                  
                  (b)   any information arising from  any investigation into, or assessment
                        of, my practice; and 
                  
                  (c)   any information arising from the  monitoring  of my compliance with
                        this Undertaking.
                  
            (20)  I,  Dr. Woolfrey, give my irrevocable consent to the College  to  provide
                  all Chief(s)  of  Staff  with any information the College has that led to
                  the  circumstances  of  my entering  into  this  Undertaking  and/or  any
                  information arising from  the  monitoring  of  my  compliance  with  this
                  Undertaking.

            (21)  I,   Dr.  Woolfrey,  give  my  irrevocable  consent  to  any  person  who
                  facilitates  my  completion  of  the  Professional  Education, and to all
                  Clinical Supervisors, Chiefs of Staff and Assessors,  to  disclose to the
                  College, and to one another, any information:

                  (a)   relevant to this Undertaking;
                  
                  (b)   relevant to the provisions of the Clinical Supervisor's undertaking
                        set out at Schedule "E";
                  
                  (c)   relevant to the Reassessment;
                  
                  (d)   relevant  for  the purposes of monitoring my compliance  with  this
                        Undertaking; and/or  
                  
                  (e)   which comes to his  or her attention in the course of providing the
                        Professional Education  and  which  he  or  she reasonably believes
                        indicates a potential risk of harm to my patients.

Concerns

Source: FSMB (USA)
Notice Type Jurisdiction Notices
Active Date: May 14, 2020
Summary: The following is a disciplinary finding made against this member by a non-Ontario Medical Regulatory Authority, as known to the College: On May 14, 2020, the North Carolina Medical Board made an Order imposing restrictions on Dr. Woolfrey’s North Carolina medical license, with Dr. Woolfrey’s consent in place of taking more formal proceedings. The Order included a requirement that Dr. Woolfrey give notice and obtain approval in advance of practising medicine in North Carolina, and practice restrictions relating to prescribing controlled substances for the treatment of chronic non-cancer pain using his N.C. medical license, performing injections to treat chronic pain and counseling for chronic pain, and restrictions on the weekly number of patients and the number of days on call. The Order was made as a result of the action taken by the College of Physicians and Surgeons of Ontario in 2019 when Dr. Woolfrey entered into an undertaking which imposed certain requirements on Dr. Woolfrey. The College was notified of this finding by a report dated June 9, 2020.

 

Source: Member
Active Date: July 2, 2019
Expiry Date:
Summary:
Summary of the Undertaking given by Dr. Michael Richard Woolfrey to the College of Physicians and Surgeons of Ontario, effective July 2, 2019:

Dr. Woolfrey was referred to the Discipline Committee on allegations of professional misconduct. In exchange for Dr. Woolfrey’s agreement to the restrictions set out below, the College withdrew the Notice of Hearing.

Dr. Woolfrey shall see a maximum of 45 patients per day and a maximum of 150 patients per week, excluding patients seen while he is on-call.

Dr. Woolfrey shall be on call no more than 10 days every three months and no more than 37 days every year.

Dr. Woolfrey shall not perform injections to treat chronic pain, but may perform injections for certain other indications as specified in the Undertaking.

Dr. Woolfrey shall not provide counseling for chronic pain and shall not bill OHIP for counseling for chronic pain.

Dr. Woolfrey will practise under the guidance of a Clinical Supervisor acceptable to the College for 12 months.

Dr. Woolfrey will engage in professional education in medical record-keeping, certain clinical guidelines, and ethics.

Dr. Woolfrey’s practice will be reassessed by an assessor selected by the College approximately 6 months after the end of the period of Clinical Supervision.

 

Source: FSMB (USA)
Notice Type Jurisdiction Notices
Active Date: March 19, 2018
Summary:

 

Source: Member
Active Date: July 5, 2017
Expiry Date:
Summary:
Summary of the Undertaking given by Dr. Michael Richard Woolfrey to the College of Physicians and Surgeons of Ontario, effective July 5, 2017:

The College received information from the Narcotics Monitoring System about Dr. Woolfrey’s prescribing of controlled substances, including narcotics.

Based on the information received, the College conducted an investigation into whether Dr. Woolfrey failed to maintain the standard of practice of the profession and/or was incompetent in his prescribing of controlled substances, including narcotics. As a result of the investigation:

Dr. Woolfrey shall not prescribe Narcotic Drugs, Narcotic Preparations, Controlled Drugs, Benzodiazepines and Other Targeted Substances and All other Monitored Drugs for chronic non-cancer pain.

Notwithstanding this restriction, Dr. Woolfrey may:

prescribe the above-noted medications for acute post-injury, post fracture or post-surgical pain; and

write hospital orders for the above-noted medications for hospital in-patients during the course of their in-patient stay to be dispensed through the hospital pharmacy only.

Dr. Woolfrey’s prescribing of narcotic drugs, narcotic preparations, controlled drugs, benzodiazepines and other targeted substances, and other monitored drugs will be supervised by a Clinical Supervisor acceptable to the College for a minimum of nine (9) months.

Dr. Woolfrey will engage in professional education in the prescribing of controlled substances, including narcotics.

Following the professional education and period of supervision, Dr. Woolfrey’s prescribing of controlled substances, including narcotics, will be re-assessed by an assessor selected by the College.

CPSO will be closed on March 29, 2024. We will re-open on Monday, April 1, 2024, at 8:00 am.